Streptococcal lung abscesses from a dental focus following tocilizumab: a case report.

@article{Kruif2012StreptococcalLA,
  title={Streptococcal lung abscesses from a dental focus following tocilizumab: a case report.},
  author={Martijn D. de Kruif and Eric van Gorp and Elisabeth H.D. Bel and Dani{\"e}lle M. Gerlag and Peter W E Kunst},
  journal={Clinical and experimental rheumatology},
  year={2012},
  volume={30 6},
  pages={951-3}
}
Patients suffering from dental infections and concurrently using immunosuppressive medication are at increased risk of developing systemic streptococcal infections. Tocilizumab is a novel therapeutic agent targeting interleukin-6. We describe a case of streptococcal lung abscesses from a dental focus after use of tocilizumab for treatment of Takayasu arteritis.